Friday, October 30, 2026||
MultiKhabarMultiKhabar
Home/finance/UBS raises Gilead Sciences stock price target on HIV strength

UBS raises Gilead Sciences stock price target on HIV strength

In
Investing.comBy Investing.com
10/30/2026, 3:00:50 PM
Share:WhatsAppFacebookX (Twitter)Telegram
UBS raises Gilead Sciences stock price target on HIV strength
EXECUTIVE SUMMARY

UBS raises Gilead Sciences stock price target on HIV strength....

Key Takeaways

  • UBS raises Gilead Sciences stock price target on HIV strength.

Share:WhatsAppFacebookX (Twitter)Telegram

Read Complete Original Article

Published originally on Investing.com

Visit Publisher Site →
OTHER MEDIA SOURCES COVERING THIS STORY
10 Publishers Reporting
Investing.com
RBC Capital raises Cemex stock price target on margin strength
Investing.com
RBC Capital raises Ollie’s Bargain Outlet stock price target to $125
Investing.com
Raymond James raises CNB Financial stock price target on fee strength
Investing.com
Truist raises Fortive stock price target to $65 on margin strength
Investing.com
Stifel raises Q2 Holdings stock price target to $85 on margin gains
Investing.com
Bernstein raises PPG Industries stock price target on Mexico strength
Investing.com
BMO Capital raises Atlassian stock price target on revenue mix
Investing.com
UBS raises Entegris stock price target to $220 on margin strength
Investing.com
Argus raises Mastercard stock price target on margin expansion

Related News

Multikhabar App

All Information In One Place

Real-time headlines from trusted sources. Get the app now — stay updated, inspired, and ahead with breaking news!

Get it on Google Play